Drug product development
Off Targets Research Private Limited operates a specialty pharmaceutical R&D facility in Bangalore, India, focused on complex formulation development, analytical development, process optimisation, scale-up support, and technology-transfer readiness for regulated markets.
The facility is designed to support development of complex injectables, sterile and non-sterile dosage forms, long-acting injectables, suspensions, emulsions, nanoparticles, lyophilised products, ready-to-use injectable formulations, ophthalmic formulations, depot systems, lipid-based formulations, and selected oral and specialty products.
Our technical capabilities include formulation screening, excipient compatibility, prototype development, particle-size engineering, high-shear mixing, homogenisation, microfluidisation, wet milling, lyophilisation cycle development, suspension and emulsion development, in-vitro performance testing, stability studies, analytical method development, assay and impurity testing, dissolution testing, reconstitution studies, syringeability, viscosity, pH, osmolality, particle-size distribution, and product-characterisation studies.
The facility is equipped with R&D-scale and pilot-support equipment including high-pressure homogenisers, microfluidisers, lyophilisers, particle-size reduction and dispersion systems, stability chambers, photostability capability, HPLC systems, GC, UV-visible spectrophotometry, dissolution apparatus, and supporting formulation and analytical laboratory infrastructure. These capabilities allow partners to evaluate early product feasibility, optimise formulation and process parameters, generate development data, and prepare products for scale-up or external GMP manufacturing.
We work with pharmaceutical companies, biotech companies, investors, CDMOs, CROs, API manufacturers, and technology partners that require specialist formulation and analytical support for difficult-to-develop pharmaceutical products. Engagements may be structured as feasibility studies, defined work packages, product-development programmes, technology-transfer support, co-development projects, or strategic partnerships.
Partners can access the facility by contacting Off Targets with a brief project overview, molecule or dosage-form information, development objective, required studies, and target timelines. Following an initial technical review, we define the scope of work, confidentiality requirements, deliverables, cost estimate, and project plan.
The facility is located in Bangalore, India, providing access to a strong scientific talent base and a cost-efficient R&D environment while supporting global pharmaceutical development standards.
About Off Targets Limited
Off Targets Limited is a pharmaceutical innovation company headquartered in London that specializes in the development of complex injectable formulations and the identification of new therapeutic indications for existing drugs. The company utilizes a multidisciplinary approach that combines various artificial intelligence and machine learning platforms with biochemical and cell-based assays. By integrating computational and experimental methodologies, the company aims to create a systematic, logical framework for drug discovery that is more efficient than serendipitous methods. Their R&D operations, which include a presence in Bangalore, India, focus on delivering ready-to-transfer technologies across areas such as central nervous system (CNS) disorders, oncology, and critical care.
This work is particularly significant for addressing unmet medical needs, especially regarding rare, neglected, and difficult-to-treat diseases. By focusing on drug repurposing, the company leverages existing safety, pharmacokinetic, and manufacturing data to expedite the development of innovative medications. This approach provides a streamlined path for bringing specialized treatments to hospital and institutional markets globally. Through its focus on complex injectables and strategic R&D, Off Targets Limited positions itself as a partner for pharmaceutical development, aiming to advance healthcare solutions through its specialized technological capabilities.
delivered to your inbox.